The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Early Results of the Revivent TC Procedure for Treatment of Left Ventricular Aneurysm and Heart Failure due to Ischemic Cardiomyopathy

DOI: 10.4244/EIJ-D-19-00225

1. Department of Cardiology, Xiamen cardiovascular hospital, Xiamen University, Xiamen, China, China
2. Xiamen cardiovascular Hospital Xiamen University, Department of Cardiology, Xiamen, China
3. Department of Cardiac surgery, Xiamen cardiovascular hospital, Xiamen University, Xiamen, China
4. Department of anesthesia, Xiamen cardiovascular hospital, Xiamen University, Xiamen , China
5. Department of Ultrasound, Xiamen cardiovascular hospital, Xiamen University, Xiamen, China
6. Interventional treatment center, Xiamen cardiovascular hospital, Xiamen University, Xiamen, China
7. Medical Office, BioVentrix, New York, USA
8. Department of Cardiology, Xiamen cardiovascular hospital, Xiamen University, Xiamen, China, China
Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please log in to download the PDF.

Left ventricular aneurysms (LVAs) is found in 10 to 30% of patients suffering from anterior myocardial infarction 1. Traditionally, scar reduction has required the use of invasive surgical techniques 2. Surgical Treatment for Ischemic Heart Failure (STICH) trial is a classic trial comparing coronary artery bypass grafting (CABG) alone with a combined procedure CABG and surgical ventricular reconstruction 3. Currently, catheter-based procedures for direct modification of the left ventricle are represented by the Parachute device and the Revivent-TC device 4-5. We report our single-center experience and outcomes of 26 patients undergoing The Revivent “Less Invasive Ventricular Enhancement” procedure, which requires no sternotomy, no ventriculotomy, extracorporeal or circulatory support.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Comparison of Diagnostic Performance of Intracoronary Optical Coherence Tomography-based and Angiography-based Fractional Flow Reserve for Evaluation of Coronary Stenosis